| 1 |
35039904 | Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. | 2022 Jan 18 |
2 |
| 2 |
35462195 | Fat mass and obesity-associated gene (FTO) hypermethylation induced by decabromodiphenyl ethane causing cardiac dysfunction via glucolipid metabolism disorder. | 2022 Jun 1 |
1 |
| 3 |
35523401 | DNMT3a negatively regulates PTEN to activate the PI3K/AKT pathway to aggravate renal fibrosis. | 2022 Aug |
1 |
| 4 |
35530273 | Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway. | 2022 |
3 |
| 5 |
29416920 | Everolimus following 5-aza-2-deoxycytidine is a promising therapy in paclitaxel-resistant clear cell carcinoma of the ovary. | 2018 |
1 |
| 6 |
28057758 | Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. | 2017 Feb 10 |
2 |
| 7 |
27573026 | 5-Azacytidine regulates matrix metalloproteinase-9 expression, and the migration and invasion of human fibrosarcoma HT1080 cells via PI3-kinase and ERK1/2 pathways. | 2016 Sep |
2 |
| 8 |
26238650 | DNA-hypomethylating agent, 5'-azacytidine, induces cyclooxygenase-2 expression via the PI3-kinase/Akt and extracellular signal-regulated kinase-1/2 pathways in human HT1080 fibrosarcoma cells. | 2015 Oct |
4 |
| 9 |
26335173 | A novel apoptosis-inducing mechanism of 5-aza-2'-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1. | 2015 Dec 28 |
2 |
| 10 |
26387181 | [Interaction between miR-21 and DNA methylation in different breast cancer cells]. | 2015 May |
1 |
| 11 |
17625605 | PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. | 2008 Jan |
1 |